Ablexis’ multi-target licensing agreement grants Almirall rights to use the AlivaMab® Mouse technology for research, development and commercialization of antibodies. AlivaMab Discovery Services will ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
New York, United States, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The Global Drug Discovery Services Market Size is to grow from USD 16.44 Billion in 2022 to USD 61.32 Billion by 2032, at a Compound Annual ...
The drug discovery services market is projected to advance from US$ 21.5 billion in 2026 to US$ 67.3 billion by 2035, compounding at a CAGR of 13.5 per cent over the forecast period. The market had ...
DALLAS--(BUSINESS WIRE)--Xerox (NYSE: XRX), today announced the acquisition of Lateral Data, a leading e-discovery technology provider, for $30 million. Lateral Data’s flagship software, Viewpoint™, ...